NCT04197986 2024-03-13PROOF302QED Therapeutics, a BridgeBio companyPhase 3 Terminated39 enrolled 31 charts
NCT01004224 2019-10-04A Dose Escalation Study in Adult Patients With Advanced Solid MalignanciesNovartisPhase 1 Completed208 enrolled